Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Based on its creator’s real-life kidney transplant, the CBS show aims for laughs and to raise awareness.
A recent survey shed light on how this rare disease affects daily life and what they value most.
On our podcast, CSL’s Chief Digital Information Officer - and Army veteran - Mark Hill discusses how technology will continue…
A world-class facility for 500 researchers is set to open in Marburg in the second half of 2022.
Alpha 1 patients send heartfelt thanks to plasma donors and those who make life-saving, plasma-derived medicines.
Get an up-close look at the albumin production process inside our Kankakee, Illinois, manufacturing site.
A mother’s memoir tells a story – both painful and joyful – about raising a daughter with a rare condition.
About a quarter of patients are hospitalized again within three months, according to new, real-world data shared at the Ameri…
CSL Behring increases capacity in Bern.
Americas
Asia Pacific
Middle East
Europe